Biomarkers for Diabetic Peripheral Artery Disease: An Integrated Review and Clinical Perspective
Diabetes/Metabolism Research and Reviews · 2026-07 · 42 (5)
DOI: 10.1002/dmrr.70200 ↗At a glance
Übersichtsarbeit in Diabetes/Metabolism Research and Reviews, published online on 2026-07-05. Written by Lihua Fang and 5 co-authors. Institution: Department of Endocrinology, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong, China. Major MEDLINE topics: Biomarkers, Peripheral Arterial Disease, Diabetic Angiopathies, Diabetes Mellitus, Type 2. 74 references. Funded by: the Scientific Research Projects of Medical and Health Institutions of Longhua District, Shenzhen, Sanming Project of the Shenzhen Longhua District Central Hospital, the Municipal Financial Subsidy of Shenzhen Longhua District Key Medical Discipline Construction.
Abstract (original language)
Type 2 diabetes mellitus and peripheral artery disease are pathophysiologically interlinked through shared mechanisms such as chronic inflammation and endothelial dysfunction, highlighting the imperative to identify common biomarkers for enhancing early detection and risk stratification. A review of PubMed through December 2025 was performed, culminating in the inclusion of 55 original studies. The synthesis revealed significant dysregulation of inflammatory markers including IL‐6 and ICAM‐1, endothelial and oxidative stress mediators such as TET3 and the PRDX family, along with coagulation markers such as von Willebrand factor and fibrinogen, all correlating with disease severity in comorbid patients. Multi‐marker panels, exemplified by the HART PAD score and combined neutrophil‐to‐HDL ratio with systemic inflammation response index, demonstrated superior predictive accuracy compared to individual biomarkers. Subsequent investigations should prioritise prospective validation and clinical standardisation of these candidate markers. This scoping review offers a novel structured integration of biomarkers across fluid, cellular and functional domains, advocating for an integrated multi‐marker strategy to facilitate personalised management in this high‐risk population.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Endocrinology, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong, China.
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China.
- Department of Public Health Data Management, Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, China.
- School of Brain Science and Rehabilitation Medicine, South China Normal University, Guangzhou, Guangdong, China.
ORCID profiles: Jie Ning
Funding
- the Scientific Research Projects of Medical and Health Institutions of Longhua District, Shenzhen
- Sanming Project of the Shenzhen Longhua District Central Hospital
- the Municipal Financial Subsidy of Shenzhen Longhua District Key Medical Discipline Construction
Cite
APA
Fang, L., Ning, Q., Wu, Y., Fang, X., Yao, Y., & Ning, J. (2026). Biomarkers for Diabetic Peripheral Artery Disease: An Integrated Review and Clinical Perspective. Diabetes/Metabolism Research and Reviews, 42(5). https://doi.org/10.1002/dmrr.70200
Vancouver
Fang L, Ning Q, Wu Y, Fang X, Yao Y, Ning J. Biomarkers for Diabetic Peripheral Artery Disease: An Integrated Review and Clinical Perspective. Diabetes/Metabolism Research and Reviews. 2026;42(5). doi:10.1002/dmrr.70200
BibTeX
@article{Fang2026,
author = {Fang, Lihua and Ning, Qing and Wu, Yuqian and Fang, Xiaokang and Yao, Yueru and Ning, Jie},
title = {Biomarkers for Diabetic Peripheral Artery Disease: An Integrated Review and Clinical Perspective},
journal = {Diabetes/Metabolism Research and Reviews},
year = {2026},
volume = {42},
number = {5},
doi = {10.1002/dmrr.70200}
}
EUVIMED